Invasive placentation and uterus preserving treatment modalities: a systematic review
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
PURPOSE: We present a systematic review to evaluate failure rates (secondary hysterectomy or maternal mortality) and success rates (subsequent menstruation or pregnancy) after different uterus preserving treatment modalities in women with invasive placentation. METHODS: A review of English, German or Dutch language-published research, using Medline and Embase databases, was performed. Studies of any design were included. RESULTS: Ten cohort studies and 50 case series or case reports were included. Expectant management reported a secondary hysterectomy in 55/287 (19%), maternal mortality in 1/295 (0.3%), a subsequent menstruation in 44/49 (90%) and a subsequent pregnancy in 24/36 (67%). Embolization of the uterine arteries described a secondary hysterectomy in 8/45 (18%), a subsequent menstruation in 8/13 (62%) and a subsequent pregnancy in 5/33 (15%). Methotrexate therapy presented a secondary hysterectomy in 1/16 (6%), a subsequent menstruation in 4/5 (80%) and a subsequent pregnancy in 1/2 (50%). Uterus preserving surgery showed a secondary hysterectomy in 24/77 (31%), maternal mortality in 2/55 (4%), a subsequent menstruation in 28/34 (82%) and a subsequent pregnancy in 19/26 (73%). CONCLUSIONS: This review indicates that different uterus preserving treatment modalities may be effective in managing invasive placentation. Despite the extensive review of the literature, no conclusions about the superiority of any modality can be drawn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A systematic review found that uterus preserving surgery resulted in a secondary hysterectomy in 24/77 women (31%), maternal mortality in 2/55 women (4%), subsequent menstruation in 28/34 women (82%) and subsequent pregnancy in 19/26 women (73%).180”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [180]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106
Case Report and Literature Review
Spoden, J. E., Bumsted, R. M., & Warner, E. D. (1980) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348948008900320 · Cited by 1,094
Understanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730 · cited 1×
“Other speciWc adverse eVects are methotrexate-related pancytopenia and nephrotoxicity [ 71 , 72].”
BackgroundThe management of placenta percreta: Conservative and operative strategies
O'Brien, J. M., Barton, J. R., & Donaldson, E. S. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70117-5 · Cited by 625
Eller, A. G., Bennett, M. A., Sharshiner, M., Masheter, C., Soisson, A. P., Dodson, M., & Silver, R. M. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182051db2 · Cited by 556 · cited 2×
“However, the proliferation of trophoblasts in the later stages of pregnancy has been shown to have no role in placental growth [67].”
BackgroundMaternal Outcome After Conservative Treatment of Placenta Accreta
Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., Perrotin, F., Winer, N., Pierre, F., Benachi, A., Dreyfus, M., et al. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181d066d4 · Cited by 515 · cited 1×
“Prophylactic antibiotics are generally administrated to prevent infection [18].”
BackgroundUterine artery embolization for symptomatic uterine fibroids
Gupta, J. K., Sinha, A., Lumsden, M. A., & Hickey, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005073.pub2 · Cited by 350
Conservative Management of Abnormally Invasive Placentation
Timmermans, S., van Hof, A. C., & Duvekot, J. J. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000271133.27011.05 · Cited by 270 · cited 2×
“[6] reported 60 cases with abnormally invasive placentation.”
BackgroundPlacenta accreta: changing clinical aspects and outcome.
Read, J. A., Cotton, D. B., & Miller, F. C. (1980) · PubMed · Cited by 236
Management of placenta accreta: Morbidity and outcome
Bretelle, F., Courbière, B., Mazouni, C., Agostini, A., Cravello, L., Boubli, L., Gamerre, M., & D’Ercole, C. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.07.050 · Cited by 232
Cited by
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,
Sentilhes, L., Kayem, G., Chandraharan, E., Palacios‐Jaraquemada, J., Jauniaux, E., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12410 · Cited by 322
Hecht, J. L., Baergen, R., Ernst, L. M., Katzman, P. J., Jacques, S. M., Jauniaux, E., Khong, T. Y., Metlay, L. A., Poder, L., Qureshi, F., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0569-1 · Cited by 263
Silver, R. M., & Barbour, K. D. (2015) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2015.01.014 · Cited by 230
Schaap, T. P., Bloemenkamp, K. W. M., Deneux‐Tharaux, C., Knight, M., Langhoff‐Roos, J., Sullivan, E. A., van den Akker, T., & INOSS (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14833 · Cited by 113
Self-citation
Metadata
- Authors
- Steins Bisschop, C. N., Schaap, T. P., Vogelvang, T. E., & Scholten, P. C.
- Affiliations
- Diakonessenhuis hospital (NL)
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2011-06-03
- Volume
- 284
- Issue
- 2
- Pages
- 491-502
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- PMC
- PMC3133648
- OpenAlex
- W1980363745
- Cited by
- 88
- References
- 74
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 4
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Trophoblastic Disease Studies
- Keywords
- invasive placentation, expectant management, uterine artery embolization, methotrexate, maternal mortality, subsequent pregnancy, treatment failure rate
- MeSH terms
- Female, Folic Acid Antagonists, Humans, Hysterectomy, Methotrexate, Placenta Accreta, Pregnancy, Uterus, Uterine Artery Embolization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive placentation and uterus preserving treatment modalities: a systematic review. https://app.cochat.ai/papers/10.1007/s00404-011-1934-6
- The paper
- Steins Bisschop, C. N., Schaap, T. P., Vogelvang, T. E., & Scholten, P. C. (2011). Invasive placentation and uterus preserving treatment modalities: a systematic review. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-011-1934-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
